Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Mar 10:14:10.
doi: 10.1186/s13034-020-00316-8. eCollection 2020.

Medications for sleep disturbance in children and adolescents with depression: a survey of Canadian child and adolescent psychiatrists

Addo Boafo  1   2   3 , Stephanie Greenham  1   4 , Marla Sullivan  1 , Khalid Bazaid  1   2 , Sinthuja Suntharalingam  1   2 , Lana Silbernagel  2 , Katherine Magner  1 , Rébecca Robillard  3   4
Affiliations

Medications for sleep disturbance in children and adolescents with depression: a survey of Canadian child and adolescent psychiatrists

Addo Boafo et al. Child Adolesc Psychiatry Ment Health. .

Abstract

Background: Primary care physicians and child and adolescent psychiatrists often treat sleep disturbances in children and adolescents with mood disorders using medications off-label, in the absence of clear evidence for efficacy, tolerability and short or long-term safety. This study is the first to report Canadian data about prescribing preferences and perceived effectiveness reported by child and adolescent psychiatrists regarding medications used to manage sleep disturbances in children and adolescents with depression.

Methods: Canadian child and adolescent psychiatrists were surveyed on their perception of effectiveness of a range of medications commonly prescribed for sleep disturbances, their ranked preferences for these medications, reasons for avoiding certain medications, and perceived side effects.

Results: Sixty-seven active child and adolescent psychiatrists completed the survey. Respondents reported noting significant sleep issues in 40% of all their patients. Melatonin and trazodone were identified as the first treatment of choice by 83% and 10% of respondents respectively, and trazodone was identified as the second treatment of choice by 56% of respondents for treating sleep disturbances in children and adolescents with depression. Melatonin (97%), trazodone (81%), and quetiapine (73%) were rated by a majority of respondents as effective. Doxepin, zaleplon, tricyclic antidepressants, zolpidem, or lorazepam were rarely prescribed due to lack of evidence and/or concerns about adverse effects, long-term safety, suitability for youth, suicidality, and dependence/tolerance.

Conclusions: Melatonin and certain off-label psychotropic drugs are perceived as being more effective and appropriate to address sleep disturbances in children and adolescents with depression. More empirical evidence on the efficacy, tolerability and indications for using these medications and newer group of sleep medications in this population is needed.

Keywords: Adolescents; Children; Depression; Sleep medications.

PubMed Disclaimer

Conflict of interest statement

Competing interestsThe authors declare that they have no competing interests.

Figures

Fig. 1
Fig. 1
First choice prescriptions. Percentages of respondents who rated melatonin, trazodone and tryptophan as first choice for treatment of sleep disturbance in children and adolescents with depression as a function of years of clinical experience and practice setting
Fig. 2
Fig. 2
Second choice prescriptions. Percentages of respondents who rated melatonin, trazodone and tryptophan as second choice for treatment of sleep disturbance in children and adolescents with depression as a function of years of clinical experience and practice setting
See this image and copyright information in PMC

References

    1. Zuckerman B, Stevenson J, Bailey V. Sleep problems in early childhood: continuities, predictive factors, and behavioral correlates. Pediatrics. 1987;80(5):664–671. - PubMed
    1. Gregory AM, Sadeh A. Sleep, emotional and behavioral difficulties in children and adolescents. Sleep Med Rev. 2012;16(2):129–136. - PubMed
    1. American Psychiatric Association . Diagnostic and statistical manual of mental disorders. 5. Arlington: American Psychiatric Association; 2013.
    1. Thapar A, Collishaw S, Pine DS, Thapar AK. Depression in adolescents. Lancet. 2012;379:1056–1067. - PMC - PubMed
    1. Statistics Canada. Table 105–1101 mental health profile, Canadian Community Health Survey—Mental Health (CCHS), by age group and sex, Canada and provinces. CANSIM (database). 2013.

LinkOut - more resources